Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2025

Stockholders' Equity Note [Abstract]

Schedule of Share-based Payment Arrangement, Restricted Stock Unit and Performance Stock Unit Activity

A summary of RSUs and PSUs for employees, consultants and non-employee directors of the Company for the nine months ended September 30, 2025 (unaudited) is as follows:

 

	Number of shares underlying outstanding RSUs and PSUs	Weighted- average grant date fair value
Unvested balance as of January 1, 2025	7,642,492	$	38.60
Granted	3,972,477	$	46.56
Vested	(2,501,144)	$	41.17
Forfeited	(487,518)	$	42.01
Unvested balance as of September 30, 2025	8,626,307	$	41.33

Schedule of Stock-Based Compensation Expense

The Company recognized stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

 

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
	(unaudited)				(unaudited)
Cost of revenues	$	1,538	$	1,357	$	4,517	$	4,017
Research and development	11,637		10,442		33,098		31,057
Sales and marketing	8,499		9,860		29,627		30,985
General and administrative	9,876		10,272		30,422		28,054
Total	$	31,550	$	31,931	$	97,664	$	94,113